Chronic myelomonocytic leukemia associated with generalized myasthenia gravis

Rudy BirsenHematology Department

Veronique MarcaudNeurology Department, Saint Joseph Hospital, Paris 5 University, Paris, France

Loukman OmarjeeInternal Medicine Department, Cochin Hospital, AP-HP, Paris 5 University, Paris, France

Philippe BlancheInternal Medicine Department, Cochin Hospital, AP-HP, Paris 5 University, Paris, France

Mathieu ZuberNeurology Department, Saint Joseph Hospital, Paris 5 University, Paris, France

Didier BouscaryHematology Department

Jerome TamburiniHematology DepartmentCorrespondence[email protected] [email protected]

show all

References

Bacher U, Haferlach T, Schnittger S, et al. Recent advances in diagnosis, molecular pathology and therapy of chronic myelomonocyticleukaemia. Br J Haematol 2011;153:149–167.
PubMed Web of Science ®Google Scholar
Levin N, Abramsky O, Lossos A, et al. Extrathymic malignancies in patients with myasthenia gravis. J Neurol Sci 2005;237:39–43.
PubMed Web of Science ®Google Scholar
Enright H, Jacob HS, Vercellotti G, et al. Paraneoplastic autoimmune phenomena in patients with myelodysplastic syndromes: response to immunosuppressive therapy. Br J Haematol 1995;91:403–408.
PubMed Web of Science ®Google Scholar
Saif MW, Hopkins JL, Gore SD. Autoimmune phenomena in patients with myelodysplastic syndromes and chronic myelomonocytic leukemia. Leuk Lymphoma 2002;43:2083–2092.
PubMed Web of Science ®Google Scholar
Knipp S, Hildebrandt B, Richter J, et al. Secondary myelodysplastic syndromes following treatment with azathioprine are associated with aberrations of chromosome 7. Haematologica 2005;90:691–693.
PubMed Web of Science ®Google Scholar
Torgerson EL, Khalili R, Dobkin BH, et al. Myasthenia gravis as a paraneoplastic syndrome associated with renal cell carcinoma. J Urol. 1999;162:154.
PubMed Web of Science ®Google Scholar
Pilorge S, Moulonguet-Doleris L, Dreyfus F, et al. The autoimmune manifestations associated with myelodysplastic syndrome respond to 5-azacytidine: a report on three cases. Br J Haematol 2011;153: 664–665.
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Chronic myelomonocytic leukemia associated with generalized myasthenia gravis

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Chronic myelomonocytic leukemia associated with generalized myasthenia gravis

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date